Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society
April 2010
in “
The Journal of Clinical Endocrinology & Metabolism
”
polycystic ovary syndrome PCOS cardiovascular disease CVD obesity dyslipidemia hypertension impaired glucose tolerance subclinical vascular disease body mass index waist circumference serum lipid levels serum glucose levels blood pressure oral glucose tolerance testing insulin-sensitizing drugs mood disorders metformin statins antihypertensives antiobesity drugs bariatric surgery BMI blood sugar levels glucose tolerance test weight loss drugs weight loss surgery
Studysummary This review examines the relationship between polycystic ovary syndrome and cardiovascular disease risk, but reports no new clinical findings; the panel calls for guidelines to prevent CVD in this population.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on academic.oup.com →